Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950144-03-003744
Filing Date
2003-03-26
Accepted
2003-03-25 18:06:08
Documents
16
Period of Report
2002-12-29

Document Format Files

Seq Description Document Type Size
1 SEROLOGICALS CORPORATION g81074e10vk.htm 10-K 872432
3 EX-2.5 SECURITY PURCHASE AGREEMENT g81074exv2w5.txt EX-2.5 230784
4 EX-2.6 EUROPEAN PURCHASE AGREEMENT g81074exv2w6.txt EX-2.6 137190
5 EX-3.1 AMENDED AND RESTATED CERTIFICATE g81074exv3w1.txt EX-3.1 56524
6 EX-10.4.1 FORMS OF SECOND REVISED STOCK OPTION g81074exv10w4w1.txt EX-10.4.1 15619
7 EX-10.4.2 FORMS OF THIRD REVISED STOCK OPTION g81074exv10w4w2.txt EX-10.4.2 17632
8 EX-10.7 1996 EMPLOYEE STOCK PURCHASE PLAN g81074exv10w7.txt EX-10.7 30042
9 EX-10.8 1996 UK SHARESAVE SCHEME g81074exv10w8.txt EX-10.8 39393
10 EX-10.19.1 SEVERANCE AGREEMENT g81074exv10w19w1.txt EX-10.19.1 7429
11 EX-10.23 EMPLOYMENT AGREEMENT g81074exv10w23.txt EX-10.23 24720
12 EX-10.24 GUARANTY AGREEMENT g81074exv10w24.txt EX-10.24 15523
13 EX-10.25 EMPLOYMENT AGREEMENT g81074exv10w25.txt EX-10.25 10146
14 EX-21 SUBSIDIARIES OF THE COMPANY g81074exv21.txt EX-21 3480
15 EX-23.1 CONSENT OF DELOITTE & TOUCHE LLP g81074exv23w1.txt EX-23.1 1304
16 EX-99.1 SECTION 906 CERTIFICATION OF THE CEO g81074exv99w1.txt EX-99.1 1055
17 EX-99.2 SECTION 906 CERTIFICATION OF THE CFO g81074exv99w2.txt EX-99.2 1077
  Complete submission text file 0000950144-03-003744.txt   1468270
Mailing Address 5655 SPALDING DRIVE 5655 SPALDING DRIVE NORCROSS GA 30092
Business Address 5655 SPALDING DRIVE 5655 SPALDING DRIVE NORCROSS GA 30092 4042965595
SEROLOGICALS CORP (Filer) CIK: 0000767673 (see all company filings)

EIN.: 582152225 | State of Incorp.: DE | Fiscal Year End: 1227
Type: 10-K | Act: 34 | File No.: 000-26126 | Film No.: 03616647
SIC: 2836 Biological Products, (No Diagnostic Substances)